{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:40:01Z","timestamp":1758958801258,"version":"3.44.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL131754"],"award-info":[{"award-number":["1R01HL131754"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-025-02040-9","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:49:56Z","timestamp":1744206596000},"page":"1555-1562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical phenotypes and outcomes associated with improved left ventricular ejection fraction after biventricular pacing"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5235-5941","authenticated-orcid":false,"given":"Sameer A.","family":"Kunte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lurdes Y. T.","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G. F.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne B.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Kutyifa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Linde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony S.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian D.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana M.","family":"Al-Khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"2","key":"2040_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/s0167-5273(99)00077-7","volume":"70","author":"W Shamim","year":"1999","unstructured":"Shamim W, Francis DP, Yousufuddin M, et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol. 1999;70(2):171\u20138. https:\/\/doi.org\/10.1016\/s0167-5273(99)00077-7.","journal-title":"Int J Cardiol"},{"issue":"3","key":"2040_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1067\/mhj.2002.121264","volume":"143","author":"S Baldasseroni","year":"2002","unstructured":"Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J. 2002;143(3):398\u2013405. https:\/\/doi.org\/10.1067\/mhj.2002.121264.","journal-title":"Am Heart J"},{"issue":"7","key":"2040_CR3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.amjcard.2019.06.024","volume":"124","author":"EL Kiehl","year":"2019","unstructured":"Kiehl EL, Menon V, Mandsager KT, et al. Effect of left ventricular conduction delay on all-cause and cardiovascular mortality (from the PRECISION trial). Am J Cardiol. 2019;124(7):1049\u201355. https:\/\/doi.org\/10.1016\/j.amjcard.2019.06.024.","journal-title":"Am J Cardiol"},{"issue":"21","key":"2040_CR4","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1161\/01.CIR.0000096580.26969.9A","volume":"108","author":"WT Abraham","year":"2003","unstructured":"Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation. 2003;108(21):2596\u2013603. https:\/\/doi.org\/10.1161\/01.CIR.0000096580.26969.9A.","journal-title":"Circulation"},{"issue":"18","key":"2040_CR5","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1056\/NEJMoa1401426","volume":"370","author":"I Goldenberg","year":"2014","unstructured":"Goldenberg I, Kutyifa V, Klein HU, et al. Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med. 2014;370(18):1694\u2013701. https:\/\/doi.org\/10.1056\/NEJMoa1401426.","journal-title":"N Engl J Med"},{"issue":"1","key":"2040_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2004.02.055","volume":"44","author":"JJ Bax","year":"2004","unstructured":"Bax JJ, Ansalone G, Breithardt OA, et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coll Cardiol. 2004;44(1):1\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2004.02.055.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"2040_CR7","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1056\/NEJMoa1210356","volume":"368","author":"AB Curtis","year":"2013","unstructured":"Curtis AB, Worley SJ, Adamson PB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med. 2013;368(17):1585\u201393. https:\/\/doi.org\/10.1056\/NEJMoa1210356.","journal-title":"N Engl J Med"},{"key":"2040_CR8","doi-asserted-by":"publisher","unstructured":"Florea VG, Rector TS, Anand IS, Cohn JN. Heart failure with improved ejection fraction: clinical characteristics, correlates of recovery, and survival: results from the valsartan heart failure trial. Circ Heart Fail. 2016;9(7). https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.116.003123.","DOI":"10.1161\/CIRCHEARTFAILURE.116.003123"},{"issue":"7","key":"2040_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.cardfail.2011.03.005","volume":"17","author":"LR Punnoose","year":"2011","unstructured":"Punnoose LR, Givertz MM, Lewis EF, Pratibhu P, Stevenson LW, Desai AS. Heart failure with recovered ejection fraction: a distinct clinical entity. J Card Fail. 2011;17(7):527\u201332. https:\/\/doi.org\/10.1016\/j.cardfail.2011.03.005.","journal-title":"J Card Fail"},{"issue":"1","key":"2040_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ahj.2011.10.001","volume":"163","author":"JE Wilcox","year":"2012","unstructured":"Wilcox JE, Fonarow GC, Yancy CW, et al. Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. Am Heart J. 2012;163(1):49-56 e2. https:\/\/doi.org\/10.1016\/j.ahj.2011.10.001.","journal-title":"Am Heart J"},{"issue":"12","key":"2040_CR11","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/ejhf.824","volume":"19","author":"J Lupon","year":"2017","unstructured":"Lupon J, Diez-Lopez C, de Antonio M, et al. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. Eur J Heart Fail. 2017;19(12):1615\u201323. https:\/\/doi.org\/10.1002\/ejhf.824.","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"2040_CR12","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1161\/01.CIR.0000065226.24159.E9","volume":"107","author":"MG St John Sutton","year":"2003","unstructured":"St John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107(15):1985\u201390. https:\/\/doi.org\/10.1161\/01.CIR.0000065226.24159.E9.","journal-title":"Circulation."},{"issue":"7","key":"2040_CR13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1161\/CIRCULATIONAHA.112.097709","volume":"126","author":"MR Gold","year":"2012","unstructured":"Gold MR, Thebault C, Linde C, et al. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study. Circulation. 2012;126(7):822\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.097709.","journal-title":"Circulation"},{"issue":"6","key":"2040_CR14","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1161\/CIRCHEARTFAILURE.113.000380","volume":"6","author":"DH Birnie","year":"2013","unstructured":"Birnie DH, Ha A, Higginson L, et al. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail. N 2013;6(6):1190\u20138. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000380.","journal-title":"Circ Heart Fail"},{"issue":"10","key":"2040_CR15","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1161\/CIRCULATIONAHA.122.062124","volume":"147","author":"DJ Friedman","year":"2023","unstructured":"Friedman DJ, Al-Khatib SM, Dalgaard F, et al. Cardiac resynchronization therapy improves outcomes in patients with intraventricular conduction delay but not right bundle branch block: a patient-level meta-analysis of randomized controlled trials. Circulation. 2023;147(10):812\u201323. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062124.","journal-title":"Circulation"},{"issue":"3","key":"2040_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/jce.13828","volume":"30","author":"EC Adelstein","year":"2019","unstructured":"Adelstein EC, Althouse AD, Davis L, et al. Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators. J Cardiovasc Electrophysiol. 2019;30(3):348\u201356. https:\/\/doi.org\/10.1111\/jce.13828.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"2040_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/sdi.12937","volume":"34","author":"Y Liu","year":"2021","unstructured":"Liu Y, Sun JY, Zhu YS, Li ZM, Li KL, Wang RX. Association between CRT(D)\/ICD and renal insufficiency: a systematic review and meta-analysis. Semin Dial. 2021;34(1):17\u201330. https:\/\/doi.org\/10.1111\/sdi.12937.","journal-title":"Semin Dial"},{"issue":"8","key":"2040_CR18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2215\/CJN.00750113","volume":"8","author":"N Garg","year":"2013","unstructured":"Garg N, Thomas G, Jackson G, et al. Cardiac resynchronization therapy in CKD: a systematic review. Clin J Am Soc Nephrol. 2013;8(8):1293\u2013303. https:\/\/doi.org\/10.2215\/CJN.00750113.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2040_CR19","doi-asserted-by":"publisher","unstructured":"Breathett K, Allen LA, Udelson J, Davis G, Bristow M. Changes in left ventricular ejection fraction predict survival and hospitalization in heart failure with reduced ejection fraction. Circ Heart Fail. 2016;9(10). https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.115.002962.","DOI":"10.1161\/CIRCHEARTFAILURE.115.002962"},{"issue":"7","key":"2040_CR20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cardfail.2015.03.006","volume":"21","author":"J Penn","year":"2015","unstructured":"Penn J, Goldenberg I, McNitt S, et al. Changes in drug utilization and outcome with cardiac resynchronization therapy: a MADIT-CRT substudy. J Card Fail. 2015;21(7):541\u20137. https:\/\/doi.org\/10.1016\/j.cardfail.2015.03.006.","journal-title":"J Card Fail"},{"issue":"1","key":"2040_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10840-018-0424-1","volume":"53","author":"M Shurrab","year":"2018","unstructured":"Shurrab M, Ko DT, Zayed Y, et al. Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients. J Interv Card Electrophysiol. 2018;53(1):123\u20139. https:\/\/doi.org\/10.1007\/s10840-018-0424-1.","journal-title":"J Interv Card Electrophysiol"},{"issue":"9","key":"2040_CR22","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.hrthm.2023.03.1538","volume":"20","author":"MK Chung","year":"2023","unstructured":"Chung MK, Patton KK, Lau CP, et al. 2023 HRS\/APHRS\/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. Heart Rhythm. 2023;20(9):e17\u201391. https:\/\/doi.org\/10.1016\/j.hrthm.2023.03.1538.","journal-title":"Heart Rhythm"},{"issue":"12","key":"2040_CR23","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/j.jcmg.2021.05.007","volume":"14","author":"H Gu","year":"2021","unstructured":"Gu H, Sidhu BS, Fang L, et al. First-phase ejection fraction predicts response to cardiac resynchronization therapy and adverse outcomes. JACC Cardiovasc Imaging. 2021;14(12):2275\u201385. https:\/\/doi.org\/10.1016\/j.jcmg.2021.05.007.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"2040_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2019-001067","volume":"6","author":"SC Harb","year":"2019","unstructured":"Harb SC, Toro S, Bullen JA, et al. Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response. Open Heart. 2019;6(2): e001067. https:\/\/doi.org\/10.1136\/openhrt-2019-001067.","journal-title":"Open Heart"},{"issue":"3","key":"2040_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJMct055185","volume":"355","author":"JA Jarcho","year":"2006","unstructured":"Jarcho JA. Biventricular pacing. N Engl J Med. 2006;355(3):288\u201394. https:\/\/doi.org\/10.1056\/NEJMct055185.","journal-title":"N Engl J Med"},{"issue":"1","key":"2040_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jacc.2004.09.058","volume":"45","author":"MV Pitzalis","year":"2005","unstructured":"Pitzalis MV, Iacoviello M, Romito R, et al. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy. J Am Coll Cardiol. 2005;45(1):65\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2004.09.058.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2040_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/HPC.0000000000000299","volume":"21","author":"SA Rizzi","year":"2022","unstructured":"Rizzi SA, Torre M, Bunch TJ, et al. Ejection fraction improvement does not reflect changes in quality of life following cardiac resynchronization therapy. Crit Pathw Cardiol. 2022;21(4):201\u20135. https:\/\/doi.org\/10.1097\/HPC.0000000000000299.","journal-title":"Crit Pathw Cardiol"},{"issue":"7","key":"2040_CR28","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/eurheartj\/ehp011","volume":"30","author":"PP Delnoy","year":"2009","unstructured":"Delnoy PP, Ottervanger JP, Luttikhuis HO, et al. Pressure-volume loop analysis during implantation of biventricular pacemaker\/cardiac resynchronization therapy device to optimize right and left ventricular pacing sites. Eur Heart J. 2009;30(7):797\u2013804. https:\/\/doi.org\/10.1093\/eurheartj\/ehp011.","journal-title":"Eur Heart J"},{"issue":"9","key":"2040_CR29","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/europace\/euq167","volume":"12","author":"MD Bogaard","year":"2010","unstructured":"Bogaard MD, Doevendans PA, Leenders GE, et al. Can optimization of pacing settings compensate for a non-optimal left ventricular pacing site? Europace. 2010;12(9):1262\u20139. https:\/\/doi.org\/10.1093\/europace\/euq167.","journal-title":"Europace"},{"issue":"10","key":"2040_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.110.960898","volume":"123","author":"W Zareba","year":"2011","unstructured":"Zareba W, Klein H, Cygankiewicz I, et al. Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011;123(10):1061\u201372. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.960898.","journal-title":"Circulation"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-025-02040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-025-02040-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-025-02040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:58:22Z","timestamp":1758956302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-025-02040-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1007\/s10840-025-02040-9","relation":{},"ISSN":["1572-8595"],"issn-type":[{"type":"electronic","value":"1572-8595"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"2 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Cleland reports grants and personal fees from Pharmacosmos; personal honoraria from Abbott, Astra Zeneca, Idorsia, Myokardia, NI Medical, Novartis, Servier, and Torrent Pharmaceuticals; grants and personal honoraria from Amgen\/Cytokinetics, Bayer, Bristol Myers Squibb, Johnson & Johnson, Medtronic, Vifor, and Viscardia; and personal honoraria and nonfinancial support from Boehringer-Ingelheim outside the submitted work.\nDr Curtis serves on medical advisory boards for Janssen Pharmaceuticals, Medtronic, Abbott, Milestone Pharmaceuticals, and Eagle Pharmaceuticals; she has received honoraria for speaking from Abbott and Medtronic. \nDr Friedman has received research support from American Heart Association, Boston Scientific, Biosense Webster, Merit Medical, Medtronic, National Institutes of Health, and Abbott and consulting fees from Abbott, AtriCure, Microport, NI Medical, and Sanofi. \nDr Gold serves on a medical advisory board for CVRx and EBR; receives research support to his institution from Boston Scientific, Abbott, and Medtronic; and is a consultant to Boston Scientific, Abbott, and Medtronic. \nDr Linde has received research support to her institution from Swedish Heart-Lung Foundation, Swedish Academy of Science, Roche Diagnostics, Astra Zeneca, and Stockholm County Council and speaker honoraria from Medtronic, Impulse Dynamics, Bayer, Boeringer Ingelheim, Novartis, Vifor Pharma, and Microport. \nThe remaining authors report no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}